Last updated: 17 November 2020 at 4:46am EST

Global Master Fund Lp Logos Net Worth




The estimated Net Worth of Global Master Fund Lp Logos is at least $12.7 Milion dollars as of 9 November 2020. Global Logos owns over 476,667 units of Miragen Therapeutics Inc stock worth over $12,655,500 and over the last 4 years Global sold MGEN stock worth over $0.

Global Logos MGEN stock SEC Form 4 insiders trading

Global has made over 1 trades of the Miragen Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Global bought 476,667 units of MGEN stock worth $2,268,935 on 9 November 2020.

The largest trade Global's ever made was buying 476,667 units of Miragen Therapeutics Inc stock on 9 November 2020 worth over $2,268,935. On average, Global trades about 476,667 units every 0 days since 2020. As of 9 November 2020 Global still owns at least 550,000 units of Miragen Therapeutics Inc stock.

You can see the complete history of Global Logos stock trades at the bottom of the page.



What's Global Logos's mailing address?

Global's mailing address filed with the SEC is C/O OGIER GLOBAL (CAYMAN) LIMITED, 89 NEXUS WAY, CAMANA BAY, E9, KY1-9009.

Insiders trading at Miragen Therapeutics Inc

Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth oraz Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.



What does Miragen Therapeutics Inc do?



Complete history of Global Logos stock trades at Miragen Therapeutics Inc

Osoba
Trans.
Transakcja
Łączna cena
Global Master Fund Lp Logos
10% właściciela
Kupować $2,268,935
9 Nov 2020


Miragen Therapeutics Inc executives and stock owners

Miragen Therapeutics Inc executives and other stock owners filed with the SEC include: